Stephens Inc Catalent, Inc. Transaction History

Stephens Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$87.2 - $114.05 $201,432 - $263,455	-2,310 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$94.19 - $124.49 $373,180 - $493,229	-3,962 Reduced 63.17%	2,310 $256,000
Q4 2021 Mar 07, 2022	SELL	$119.57 - $139.07 $385,732 - $448,639	-3,226 Reduced 33.97%	6,272 $803,000
Q3 2021 Oct 27, 2021	BUY	$109.17 - $142.35 $45,960 - $59,929	421 Added 4.64%	9,498 $1.26 Million
Q2 2021 Aug 12, 2021	BUY	$100.34 - $115.69 $702 - $809	7 Added 0.08%	9,077 $981,000
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $11,876 - $14,656	-117 Reduced 1.27%	9,070 $955,000
Q4 2020 Feb 10, 2021	SELL	$85.88 - $105.36 $159,994 - $196,285	-1,863 Reduced 16.86%	9,187 $956,000
Q3 2020 Nov 13, 2020	BUY	$72.74 - $92.5 $48,808 - $62,067	671 Added 6.46%	11,050 $947,000
Q2 2020 Aug 24, 2020	BUY	$48.02 - $79.04 $115,632 - $190,328	2,408 Added 30.21%	10,379 $761,000
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $294,528 - $501,774	7,971 New	7,971 $414,000

489

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.